{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:51:06Z","timestamp":1794293466092,"version":"4.9.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.msard.2025.106666","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T23:58:55Z","timestamp":1754438335000},"page":"106666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Glial-mediated pathogenesis and intervention strategies in neuromyelitis optica spectrum disorder"],"prefix":"10.1016","volume":"103","author":[{"given":"Zixin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0554-642X","authenticated-orcid":false,"given":"Hongen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0001","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/s41467-020-16625-7","article-title":"Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica","volume":"11","author":"Agasing","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.msard.2025.106666_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.844194","article-title":"Role of extracellular vesicles in glia-neuron intercellular communication","volume":"15","author":"Ahmad","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"6411","key":"10.1016\/j.msard.2025.106666_bib0003","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.aat0473","article-title":"Glia as architects of central nervous system formation and function","volume":"362","author":"Allen","year":"2018","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.msard.2025.106666_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/cells13060485","article-title":"NF-\u03baB as an inducible regulator of inflammation in the Central nervous system","volume":"13","author":"Anilkumar","year":"2024","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.msard.2025.106666_bib0005","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/brain\/awad373","article-title":"Interferon-\u03b3 controls aquaporin 4-specific Th17 and B cells in neuromyelitis optica spectrum disorder","volume":"147","author":"Arellano","year":"2024","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.msard.2025.106666_bib0006","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm.2110","article-title":"T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis","volume":"16","author":"Axtell","year":"2010","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0007","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-065X.2012.01131.x","article-title":"Janus-like effects of type I interferon in autoimmune diseases","volume":"248","author":"Axtell","year":"2012","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.msard.2025.106666_bib0008","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1212\/NXI.0000000000000104","article-title":"B lymphocytes in neuromyelitis optica","volume":"2","author":"Bennett","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"10.1016\/j.msard.2025.106666_bib0009","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/sj.eye.6701595","article-title":"Functions of optic nerve glia: axoglial signalling in physiology and pathology","volume":"18","author":"Butt","year":"2004","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.msard.2025.106666_bib0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/1352458518813105","article-title":"Area postrema syndrome: a short history of a pearl in demyelinating diseases","volume":"25","author":"Camara-Lemarroy","year":"2019","journal-title":"Mult Scler"},{"issue":"11","key":"10.1016\/j.msard.2025.106666_bib0011","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/glia.22878","article-title":"Mechanisms underlying AQP4 accumulation in astrocyte endfeet","volume":"63","author":"Camassa","year":"2015","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0012","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"8","key":"10.1016\/j.msard.2025.106666_bib0014","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s12264-023-01166-y","article-title":"Serum LDL promotes microglial activation and exacerbates demyelinating injury in Neuromyelitis Optica spectrum disorder","volume":"40","author":"Chen","year":"2024","journal-title":"Neurosci Bull"},{"issue":"8","key":"10.1016\/j.msard.2025.106666_bib0015","first-page":"4025","article-title":"Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.msard.2025.106666_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107448","article-title":"Regulation of microglia inflammation and oligodendrocyte demyelination by Engeletin via the TLR4\/RRP9\/NF-\u03bab pathway after spinal cord injury","volume":"209","author":"Chen","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.msard.2025.106666_bib0017","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the Central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.regpep.2003.09.004","article-title":"Sensory circumventricular organs: central roles in integrated autonomic regulation","volume":"117","author":"Cottrell","year":"2004","journal-title":"Regul Pept"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0019","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12967-023-04741-z","article-title":"A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway","volume":"22","author":"Dai","year":"2024","journal-title":"J Transl Med"},{"issue":"15","key":"10.1016\/j.msard.2025.106666_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22157925","article-title":"Cells to the rescue: emerging cell-based treatment approaches for NMOSD and MOGAD","volume":"22","author":"Derdelinckx","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.msard.2025.106666_bib0021","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nn1885","article-title":"Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model","volume":"10","author":"Di Giorgio","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.msard.2025.106666_bib0022","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-neuro-091922-031205","article-title":"Astrocyte endfeet in brain function and pathology: open questions","volume":"46","author":"D\u00edaz-Castro","year":"2023","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"10.1016\/j.msard.2025.106666_bib0023","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.celrep.2018.06.046","article-title":"B-cell-intrinsic type 1 interferon signaling is crucial for loss of tolerance and the development of autoreactive B cells","volume":"24","author":"Domeier","year":"2018","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.msard.2025.106666_bib0024","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1023\/A:1021608724117","article-title":"Expression of the p75 TNF receptor is linked to TNF-induced NFkappaB translocation and oxyradical neutralization in glial cells","volume":"27","author":"Dopp","year":"2002","journal-title":"Neurochem Res"},{"key":"10.1016\/j.msard.2025.106666_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.653101","article-title":"Neuron-oligodendrocyte interactions in the structure and integrity of axons","volume":"9","author":"Duncan","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.msard.2025.106666_bib0026","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/1735-1995.200275","article-title":"Efficacy and safety of rituximab in neuromyelitis optica: review of evidence","volume":"22","author":"Etemadifar","year":"2017","journal-title":"J Res Med Sci"},{"issue":"4","key":"10.1016\/j.msard.2025.106666_bib0027","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40263-023-00995-9","article-title":"Satralizumab: a review in Neuromyelitis Optica spectrum disorder","volume":"37","author":"Fung","year":"2023","journal-title":"CNS Drugs"},{"issue":"Pt B","key":"10.1016\/j.msard.2025.106666_bib0028","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.expneurol.2016.03.008","article-title":"Intracellular signaling pathway regulation of myelination and remyelination in the CNS","volume":"283","author":"Gaesser","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1016\/j.msard.2025.106666_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.624983","article-title":"Glial cells in glaucoma: friends, foes, and potential therapeutic targets","volume":"12","author":"Garc\u00eda-Berm\u00fadez","year":"2021","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.msard.2025.106666_bib0030","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s13311-018-0630-7","article-title":"Glial cells shape pathology and repair after spinal cord injury","volume":"15","author":"Gaudet","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"22","key":"10.1016\/j.msard.2025.106666_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221834","article-title":"The yin and yang of microglia-derived extracellular vesicles in CNS injury and diseases","volume":"13","author":"Ghosh","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.msard.2025.106666_bib0032","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3389\/fcell.2017.00117","article-title":"The importance of non-neuronal cell types in hiPSC-based disease modeling and drug screening [Review]","volume":"Volume 5","author":"Gonzalez","year":"2017","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.msard.2025.106666_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102261","article-title":"Recent insights into astrocytes as therapeutic targets for demyelinating diseases","volume":"65","author":"Gorter","year":"2022","journal-title":"Curr Opin Pharmacol"},{"issue":"10","key":"10.1016\/j.msard.2025.106666_bib0034","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/glia.22842","article-title":"The control of reactive oxygen species production by SHP-1 in oligodendrocytes","volume":"63","author":"Gruber","year":"2015","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.msard.2025.106666_bib0035","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.nrl.2017.07.021","article-title":"The role of astrocytes in multiple sclerosis pathogenesis","volume":"35","author":"Guerrero-Garc\u00eda","year":"2020","journal-title":"Neurologia (Engl Ed)"},{"issue":"6","key":"10.1016\/j.msard.2025.106666_bib0036","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/stem.2995","article-title":"Concise review: modeling neurodegenerative diseases with Human pluripotent stem cell-derived microglia","volume":"37","author":"Haenseler","year":"2019","journal-title":"STEM CELLS"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0037","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","article-title":"Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-State changes","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.msard.2025.106666_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577925","article-title":"IL-6 as a marker for NMOSD disease activity","volume":"370","author":"Haramati","year":"2022","journal-title":"J Neuroimmunol"},{"issue":"14","key":"10.1016\/j.msard.2025.106666_bib0039","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s40265-020-01380-2","article-title":"Satralizumab: first approval","volume":"80","author":"Heo","year":"2020","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.msard.2025.106666_bib0040","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1073\/pnas.1109980108","article-title":"Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes","volume":"109","author":"Hinson","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.msard.2025.106666_bib0041","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/glia.23780","article-title":"Emerging technologies to study glial cells","volume":"68","author":"Hirbec","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.msard.2025.106666_bib0042","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneuroim.2016.06.008","article-title":"Microglia response in retina and optic nerve in chronic experimental autoimmune encephalomyelitis","volume":"298","author":"Horstmann","year":"2016","journal-title":"J Neuroimmunol"},{"issue":"8","key":"10.1016\/j.msard.2025.106666_bib0043","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41577-021-00652-6","article-title":"B cells in central nervous system disease: diversity, locations and pathophysiology","volume":"22","author":"Jain","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.msard.2025.106666_bib0044","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: clinical features, immunopathogenesis and treatment","volume":"176","author":"Jarius","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"Pt 12","key":"10.1016\/j.msard.2025.106666_bib0045","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awm263","article-title":"Serum GFAP is a diagnostic marker for glioblastoma multiforme","volume":"130","author":"Jung","year":"2007","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/neurolint17010006","article-title":"The rise of pluripotent stem cell-derived glia models of neuroinflammation","volume":"17","author":"Kala","year":"2025","journal-title":"Neurol Int"},{"issue":"2","key":"10.1016\/j.msard.2025.106666_bib0047","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/imm.13663","article-title":"Complement: functions, location and implications","volume":"170","author":"Kareem","year":"2023","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0048","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1038\/s41467-019-11638-3","article-title":"Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination","volume":"10","author":"Kirby","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.msard.2025.106666_bib0049","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1352458507082075","article-title":"Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis","volume":"14","author":"Koch","year":"2008","journal-title":"Mult Scler"},{"issue":"23","key":"10.1016\/j.msard.2025.106666_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316731","article-title":"Antioxidant, anti-inflammatory and pro-differentiative effects of chlorogenic acid on M03-13 Human oligodendrocyte-like cells","volume":"24","author":"La Rosa","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.msard.2025.106666_bib0051","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41573-022-00390-x","article-title":"Function and therapeutic value of astrocytes in neurological diseases","volume":"21","author":"Lee","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.msard.2025.106666_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114576","article-title":"IL-6\/JAK2\/STAT3 axis mediates neuropathic pain by regulating astrocyte and microglia activation after spinal cord injury","volume":"370","author":"Lee","year":"2023","journal-title":"Exp Neurol"},{"issue":"9451","key":"10.1016\/j.msard.2025.106666_bib0053","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2025.106666_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106209","article-title":"Relapse risk factors analysis within 1 year after the first onset of neuromyelitis optica spectrum disorders: a two-center retrospective study","volume":"93","author":"Li","year":"2025","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00441-020-03195-9","article-title":"The roles of neuron-NG2 glia synapses in promoting oligodendrocyte development and remyelination","volume":"381","author":"Li","year":"2020","journal-title":"Cell Tissue Res"},{"issue":"14","key":"10.1016\/j.msard.2025.106666_bib0056","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.7150\/ijms.61153","article-title":"The role and mechanisms of microglia in Neuromyelitis Optica Spectrum disorders","volume":"18","author":"Li","year":"2021","journal-title":"Int J Med Sci"},{"issue":"4","key":"10.1016\/j.msard.2025.106666_bib0057","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","article-title":"Astrocyte crosstalk in CNS inflammation","volume":"108","author":"Linnerbauer","year":"2020","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0058","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12974-023-02997-2","article-title":"Bruton's tyrosine kinase-bearing B cells and microglia in neuromyelitis optica spectrum disorder","volume":"20","author":"Liu","year":"2023","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1016\/j.msard.2025.106666_bib0059","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00401-019-02049-1","article-title":"Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure","volume":"138","author":"Lombardi","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.1016\/j.msard.2025.106666_bib0060","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1002\/cti2.1316","article-title":"Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"10","author":"Lopez","year":"2021","journal-title":"Clin Transl Immunology"},{"issue":"7","key":"10.1016\/j.msard.2025.106666_bib0061","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/cells13070606","article-title":"Human glial cells as innovative targets for the therapy of Central nervous system pathologies","volume":"13","author":"Magni","year":"2024","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.msard.2025.106666_bib0062","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.celrep.2020.01.010","article-title":"Microglia heterogeneity in the single-cell era","volume":"30","author":"Masuda","year":"2020","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.msard.2025.106666_bib0063","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/glia.22307","article-title":"Regulation of CCL20 expression in astrocytes by IL-6 and IL-17","volume":"60","author":"Meares","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.msard.2025.106666_bib0064","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fcell.2020.00809","article-title":"Novel glial cell functions: extensive potency, stem cell-like properties, and participation in regeneration and transdifferentiation","volume":"8","author":"Milichko","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"10.1016\/j.msard.2025.106666_bib0065","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.msard.2025.106666_bib0066","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1620\/tjem.209.269","article-title":"Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report","volume":"209","author":"Misu","year":"2006","journal-title":"Tohoku J Exp Med"},{"issue":"6","key":"10.1016\/j.msard.2025.106666_bib0067","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00401-013-1116-7","article-title":"Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica","volume":"125","author":"Misu","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"10","key":"10.1016\/j.msard.2025.106666_bib0068","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s40263-022-00949-7","article-title":"Inebilizumab: a review in Neuromyelitis Optica spectrum disorder","volume":"36","author":"Nie","year":"2022","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.msard.2025.106666_bib0069","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2 polarization and metabolic states","volume":"173","author":"Orihuela","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.msard.2025.106666_bib0070","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3390\/cimb45020094","article-title":"Multiple sclerosis: inflammatory and neuroglial aspects","volume":"45","author":"Papiri","year":"2023","journal-title":"Curr Issues Mol Biol"},{"issue":"7","key":"10.1016\/j.msard.2025.106666_bib0071","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","article-title":"Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration","volume":"19","author":"Patani","year":"2023","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.msard.2025.106666_bib0072","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00401-015-1513-1","article-title":"Astrocytes: a central element in neurological diseases","volume":"131","author":"Pekny","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.1016\/j.msard.2025.106666_bib0073","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in Aquaporin-4-positive Neuromyelitis Optica spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N Engl J Med"},{"issue":"7751","key":"10.1016\/j.msard.2025.106666_bib0074","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41586-019-1088-4","article-title":"CD22 blockade restores homeostatic microglial phagocytosis in ageing brains","volume":"568","author":"Pluvinage","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.msard.2025.106666_bib0075","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","article-title":"Microglia biology: one century of evolving concepts","volume":"179","author":"Prinz","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0076","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/brain\/awad321","article-title":"Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders","volume":"147","author":"Qin","year":"2024","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0077","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41232-022-00193-y","article-title":"Central nervous system regeneration: the roles of glial cells in the potential molecular mechanism underlying remyelination","volume":"42","author":"Quan","year":"2022","journal-title":"Inflamm Regen"},{"issue":"8","key":"10.1016\/j.msard.2025.106666_bib0078","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1172\/JCI95769","article-title":"Astrocytes to the rescue! glia limitans astrocytic endfeet control CNS inflammation","volume":"127","author":"Quintana","year":"2017","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.msard.2025.106666_bib0079","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nn.4338","article-title":"A polarizing question: do M1 and M2 microglia exist?","volume":"19","author":"Ransohoff","year":"2016","journal-title":"Nat Neurosci"},{"issue":"5250","key":"10.1016\/j.msard.2025.106666_bib0080","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1126\/science.271.5250.822","article-title":"Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases","volume":"271","author":"Rawlings","year":"1996","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.msard.2025.106666_bib0081","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/glia.23727","article-title":"Glia of the human retina","volume":"68","author":"Reichenbach","year":"2020","journal-title":"Glia"},{"issue":"7707","key":"10.1016\/j.msard.2025.106666_bib0082","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41586-018-0119-x","article-title":"Microglial control of astrocytes in response to microbial metabolites","volume":"557","author":"Rothhammer","year":"2018","journal-title":"Nature"},{"issue":"7846","key":"10.1016\/j.msard.2025.106666_bib0083","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-020-03116-4","article-title":"Gut-licensed IFN\u03b3(+) NK cells drive LAMP1(+)TRAIL(+) anti-inflammatory astrocytes","volume":"590","author":"Sanmarco","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.msard.2025.106666_bib0084","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4939-9658-2_2","article-title":"Morphology of microglia across contexts of health and disease","volume":"2034","author":"Savage","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"9","key":"10.1016\/j.msard.2025.106666_bib0085","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nn.2172","article-title":"Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency","volume":"11","author":"Shen","year":"2008","journal-title":"Nat Neurosci"},{"issue":"5","key":"10.1016\/j.msard.2025.106666_bib0086","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25053050","article-title":"Astrocyte-neuron interaction via the glutamate-glutamine cycle and its dysfunction in tau-dependent neurodegeneration","volume":"25","author":"Sidoryk-W\u0119grzynowicz","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.msard.2025.106666_bib0087","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fnins.2015.00248","article-title":"Neuronal and microglial regulators of cortical wiring: usual and novel guideposts","volume":"9","author":"Squarzoni","year":"2015","journal-title":"Front Neurosci"},{"issue":"10","key":"10.1016\/j.msard.2025.106666_bib0088","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.it.2024.08.004","article-title":"Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine","volume":"45","author":"Summers","year":"2024","journal-title":"Trends Immunol"},{"issue":"4","key":"10.1016\/j.msard.2025.106666_bib0089","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1474-4422(20)30066-1","article-title":"Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"19","author":"Tahara","year":"2020","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.msard.2025.106666_bib0090","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001076","article-title":"New BBB model reveals that IL-6 blockade suppressed the BBB disorder, preventing onset of NMOSD","volume":"8","author":"Takeshita","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"17","key":"10.1016\/j.msard.2025.106666_bib0091","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179588","article-title":"Glial cells as key regulators in neuroinflammatory mechanisms associated with multiple sclerosis","volume":"25","author":"Theophanous","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.msard.2025.106666_bib0092","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.5966\/sctm.2016-0024","article-title":"Survival and functionality of Human induced pluripotent stem cell-derived oligodendrocytes in a nonhuman primate model for multiple sclerosis","volume":"5","author":"Thiruvalluvan","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.msard.2025.106666_bib0093","article-title":"Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: a national population-based study","volume":"2","author":"Tian","year":"2020","journal-title":"Lancet Reg Health West Pac"},{"issue":"6271","key":"10.1016\/j.msard.2025.106666_bib0094","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1126\/science.aad3839","article-title":"Oligodendrocyte precursors migrate along vasculature in the developing nervous system","volume":"351","author":"Tsai","year":"2016","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.msard.2025.106666_bib0095","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: an evolving disease spectrum","volume":"20","author":"Uzawa","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0096","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.23651","article-title":"Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter","volume":"72","author":"Varrin-Doyer","year":"2012","journal-title":"Ann Neurol"},{"issue":"Pt A","key":"10.1016\/j.msard.2025.106666_bib0097","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.msard.2025.106666_bib0098","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062801","article-title":"Neuromyelitis Optica spectrum Disorder treatment-current and future prospects","volume":"22","author":"Waliszewska-Pros\u00f3\u0142","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.msard.2025.106666_bib0099","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neuroscience.2022.05.038","article-title":"NMO-IgG induce interleukin-6 release via activation of the NF-\u03bab signaling pathway in astrocytes","volume":"496","author":"Wang","year":"2022","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jnc.16011","article-title":"Microglia-derived extracellular vesicles in homeostasis and demyelination\/remyelination processes","volume":"168","author":"Wies Mancini","year":"2024","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0101","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(19)30445-4","article-title":"Neuromyelitis optica in patients with increased interferon alpha concentrations","volume":"19","author":"Williams","year":"2020","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.msard.2025.106666_bib0102","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2025.106666_bib0103","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/glia.23938","article-title":"Type I interferon-activated microglia are critical for neuromyelitis optica pathology","volume":"69","author":"Wlodarczyk","year":"2021","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.msard.2025.106666_bib0104","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4103\/NRR.NRR-D-23-01325","article-title":"Aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress of experimental models based on disease pathogenesis","volume":"20","author":"Xu","year":"2025","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.msard.2025.106666_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100886","article-title":"Role of glia in optic nerve","volume":"81","author":"Yazdankhah","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"10.1016\/j.msard.2025.106666_bib0106","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nn.2333","article-title":"HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction","volume":"12","author":"Ye","year":"2009","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0107","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001110","article-title":"Demystifying MOGAD and double seronegative NMOSD further with IL-6 blockade","volume":"9","author":"Yong","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0108","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-023-02772-3","article-title":"TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder","volume":"20","author":"You","year":"2023","journal-title":"J Neuroinflammation"},{"issue":"Pt A","key":"10.1016\/j.msard.2025.106666_bib0109","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2015.09.021","article-title":"The immunomodulatory oligodendrocyte","volume":"1641","author":"Zeis","year":"2016","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.msard.2025.106666_bib0110","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/neuroglia4030013","article-title":"Unraveling the critical mechanisms and functions of neuroglia in spinal cord injuries","volume":"4","author":"Zeng","year":"2023","journal-title":"Neuroglia"},{"issue":"6","key":"10.1016\/j.msard.2025.106666_bib0111","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ana.22551","article-title":"Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.msard.2025.106666_bib0112","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12974-024-03305-2","article-title":"CD22 blockade exacerbates neuroinflammation in Neuromyelitis optica spectrum disorder","volume":"21","author":"Zhang","year":"2024","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10.1016\/j.msard.2025.106666_bib0113","first-page":"524","article-title":"[Mechanisms underlying remyelination with special focus on demyelination models of multiple sclerosis]","volume":"49","author":"Zheng","year":"2020","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825004080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825004080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:18:28Z","timestamp":1774999108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825004080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":112,"alternative-id":["S2211034825004080"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106666","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glial-mediated pathogenesis and intervention strategies in neuromyelitis optica spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106666"}}